معرفی
James Fluckey is the Associate Dean for Research and Professor in the Department of Kinesiology and Sport Management at Texas A&M University's College of Education and Human Development. He holds a Ph.D. in Physiology from Pennsylvania State University (1995), an M.S. in Exercise Physiology from Ball State University (1992), and a B.S. in Health and Physical Education from Eastern New Mexico University (1990). His research focuses on muscle physiology, exercise-induced adaptations, and mechanisms of muscle atrophy, with particular emphasis on skeletal muscle responses to disuse, aging, and metabolic disorders.
Research interests include the role of exercise in mitigating muscle atrophy during spaceflight, insulin resistance, protein synthesis regulation, and the intersection of exercise and cancer biology. He has led over 30 research projects funded by NASA, NIH, and industry partners, including studies on microgravity countermeasures and muscle-cancer cross-talk. Notable awards include a Fulbright Fellowship (1995) and the CEHD Service Award (2015).
- Education:
- Ph.D., Physiology, Pennsylvania State University (1995)
- M.S., Exercise Physiology, Ball State University (1992)
- B.S., Health and Physical Education, Eastern New Mexico University (1990)
Key research projects include investigating the effects of resistance exercise on muscle protein synthesis, developing countermeasures for muscle atrophy in microgravity, and exploring exercise-induced myokines as potential cancer therapies. He has advised over 10 doctoral students and published extensively in journals like Journal of Cellular Biochemistry and American Journal of Physiology.
- Grants & Awards:
- Fulbright Fellowship (1995)
- NASA grants (e.g., Upstream Regulation of Nox2 and Skeletal Muscle Atrophy During Microgravity)
- National Institutes of Health (NIH) grants on muscle mechanisms and aging
His work bridges basic science and applied research, with implications for astronaut health, aging populations, and cancer therapy. He actively collaborates with NASA, academic institutions, and industry on translational studies.
